Denali to Sell Rare Pediatric Disease Voucher for $195M Cash Infusion
Reported by Dow Jones Newswires
Sentiment
Positive
Importance
9
Price
$23.89
Mkt Cap
$3.728B
52W Low
$12.58
52W High
$24.205
Market data snapshot near publication time
Summary
Denali Therapeutics has entered an agreement to sell a Rare Pediatric Disease Priority Review Voucher for $195 million. This significant non-dilutive cash infusion follows the FDA accelerated approval of AVLAYAH for Hunter syndrome in March, which likely generated the voucher. The sale substantially boosts the company's cash reserves and financial flexibility, monetizing a key regulatory asset.
At the time of this announcement, DNLI was trading at $23.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $12.58 to $24.21. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.
Price Chart
DNLI - Latest Insights
DNLI
Jun 18, 2026, 8:01 AM EDT
Price at Filing:
$23.89
Real-time Price:
$23.90
Change:
+$0.0100 (+0.04%)
Market Cap:
$3.728B
DNLI
Jun 18, 2026, 8:01 AM EDT
Price at Filing:
$23.89
Real-time Price:
$23.90
Change:
+$0.0100 (+0.04%)
Market Cap:
$3.728B
DNLI
May 22, 2026, 6:03 AM EDT
Price at Filing:
$17.86
Real-time Price:
$23.90
Change:
+$6.04 (+34%)
Market Cap:
$3.728B
DNLI
May 21, 2026, 6:17 PM EDT
Price at Filing:
$17.86
Real-time Price:
$23.90
Change:
+$6.04 (+34%)
Market Cap:
$3.728B
DNLI
May 07, 2026, 4:32 PM EDT
Price at Filing:
$19.71
Real-time Price:
$23.90
Change:
+$4.19 (+21%)
Market Cap:
$3.728B
DNLI
May 07, 2026, 4:12 PM EDT
Price at Filing:
$19.71
Real-time Price:
$23.90
Change:
+$4.19 (+21%)
Market Cap:
$3.728B
DNLI
May 07, 2026, 4:03 PM EDT
Price at Filing:
$19.71
Real-time Price:
$23.90
Change:
+$4.19 (+21%)
Market Cap:
$3.728B
DNLI
Apr 03, 2026, 2:43 PM EDT
Price at Filing:
$20.80
Real-time Price:
$23.90
Change:
+$3.10 (+15%)
Market Cap:
$3.728B
DNLI
Apr 03, 2026, 1:30 PM EDT
Price at Filing:
$20.80
Real-time Price:
$23.90
Change:
+$3.10 (+15%)
Market Cap:
$3.728B
DNLI
Mar 31, 2026, 8:30 AM EDT
Price at Filing:
$19.14
Real-time Price:
$23.90
Change:
+$4.76 (+25%)
Market Cap:
$3.728B